An Interview w/ Volcanologists, 2016 Nobel Prizes, Bugs R'Us, Smart Bees, Buzzed Bees, Ancient Loot Tales, Politics Of Change, The Atlantic Conveyor, Zap And Tingle, Sideways Sharks, And Much More...
NYS Entity Status
NYS Filing Date
MARCH 19, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2014 - ATLANTIC PHYSICAL THERAPY & CHIROPRACTIC OF NEW YORK, PLLC
AROUND THE WEB
- 05 October, 2016 – Episode 587 – This Week in Science Podcast (TWIS)
By Kirsten Sanford - Thursday Oct 6, 2016
- For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
By Ben Fidler - Wednesday Aug 9, 2017
A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]
- Mt. Sinai's new therapy dog is a mutt with a mission
By Peter D'Amato - Thursday Aug 10, 2017
Midway through his shift at Mount Sinai’s Kravis Children’s Hospital, the health system’s youngest worker was doing his rounds—on four legs. Professor Bunsen...
To view the full story, click the title link.
- Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups
By David Holley - Wednesday Jul 26, 2017
Genomics startups are increasing in number and quality, so much so that three-year-old Illumina Accelerator has expanded with its latest class to accommodate five of them. Xconomy got an early look at the specialty accelerator’s sixth cohort, which includes a company named for a butterfly and the accelerator’s first digital health startup. Illumina (NASDAQ: ILMN), […]
- Novel leukemia treatment could be 1st US gene therapy
By Associated Press - Thursday Jul 13, 2017
A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations from its expert panels, but isn’t...